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Immune memory cells are poised to rapidly expand
and elaborate effector functions upon reinfection
yet exist in a functionally quiescent state. The para-
digm is that memory T cells remain inactive due to
lack of T cell receptor (TCR) stimuli. Here, we report
that regulatory T (Treg) cells orchestrate memory
T cell quiescence by suppressing effector and prolif-
eration programs through inhibitory receptor, cyto-
toxic-T-lymphocyte-associated protein-4 (CTLA-4).
Loss of Treg cells resulted in activation of genome-
wide transcriptional programs characteristic of
effector T cells and drove transitioning as well as es-
tablished memory CD8+ T cells toward terminally
differentiated KLRG-1hiIL-7RaloGzmBhi phenotype,
with compromisedmetabolic fitness, longevity, poly-
functionality, and protective efficacy. CTLA-4 func-
tionally replaced Treg cells in trans to rescuememory
Tcell defects and restorehomeostasis. Thesestudies
present the CTLA-4-CD28-CD80/CD86 axis as a po-
tential target to accelerate vaccine-induced immu-
nity and improve T cell memory quality in current
cancer immunotherapies proposing transient Treg
cell ablation.
INTRODUCTION
Effector T cell responses to foreign antigens as well as self-an-
tigens are effectively controlled by suppressive functions of
FoxP3+ regulatory T (Treg) cells (Campbell and Koch, 2011;
Wing and Sakaguchi, 2010). During early stages of infection
or vaccination, ablation of Treg cells leads to increased magni-
tude (Rouse et al., 2006; Suvas et al., 2003) of effector and
memory T cells. Hence, removal of Treg cells during primary
as well as secondary immune responses has been proposed
to enhance T cell immunity following immunization. However,
effector and memory T cell clones primed in the absence of
Treg cells are typically of low avidity (Pace et al., 2012).
Absence of Treg cells during primary T cell responses is also
associated with a dysregulation of the chemokine milieu
(Lund et al., 2008; Pace et al., 2012), altered T cell localization
(Graham et al., 2014), and compromised pathogen clearance1116 Immunity 42, 1116–1129, June 16, 2015 ª2015 Elsevier Inc.(Lund et al., 2008). Prolonged instructional cues from antigen
or cytokines such as interleukin-2 (IL-2) and IL-12, which may
occur due to loss of Treg cells during priming, are associated
with terminal effector differentiation and impaired programming
of memory potential (Joshi et al., 2007; Kalia et al., 2010a; Kalia
et al., 2010b; Sarkar et al., 2008). Thus, Treg cells regulate
various aspects of antigen-driven T cell differentiation during
priming to putatively curb excessive stimulation and immuno-
pathology associated with the explosive burst of antigen-spe-
cific effector T cells during infections.
Once antigen is cleared, effector T cell response is largely
culled through apoptotic elimination of short-lived effector cells
(SLECs), which typically comprise 90%–95% of the peak anti-
gen-specific T cell pool (Williams and Bevan, 2007). The remain-
ing 5%–10% of effectors, which are programmed with memory
potential during priming (memory precursor effector cells
[MPECs]), preferentially survive and progressively differentiate
into memory by downregulating cytotoxic effector programs
and acquiring cardinal memory properties of antigen-indepen-
dent longevity and secondary expansion. Conversion of MPECs
from a highly charged effector state to a quiescent memory
state occurs passively on ‘‘autopilot’’ in the absence of antigen
(Kaech and Ahmed, 2001; Kaech et al., 2002; van Stipdonk
et al., 2001) and is proposed to result from lack of continued
T cell receptor (TCR) stimulation. Indeed effective transition
into quiescent memory T cells does not occur under conditions
of chronic antigenic stimuli (Wherry, 2011). Likewise, it is
believed that fully differentiated memory T cells also remain in
a quiescent state for the life of an individual in the absence of
reinfection due to lack of cognate antigenic stimulation (Ban-
nard et al., 2009; Murali-Krishna et al., 1999; Tanchot et al.,
1997). In this study, we asked the question of whether in
addition to antigenic rest, suppressive signals from Treg cells
promote the development and long-term maintenance of mem-
ory T cell quiescence under homeostatic conditions. To address
this issue, we took advantage of genetically targeted Foxp3DTR
mice (Kim et al., 2007), in which Treg cells express the
human diphtheria toxin receptor (DTR). We ablated Treg cells
specifically during two distinct phases of memory after acute
infection with lymphocytic choriomeningitis virus (LCMV):
(1) effector-to-memory (E/M) transition after pathogen clear-
ance or (2) memory maintenance phase after fully functional,
quiescent, long-lived memory T cells are formed. We found
that Treg cells were required during both stages to institute
quiescence and promote memory function by blocking T cell
activation through the CD28-CTLA-4 axis.
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Figure 1. Increased Effector Differentiation and Proliferation upon Treg Cell Ablation during Effector-to-Memory Transition and Memory
Maintenance Phases
(A) Effect of Treg cell ablation on expression of effector molecule, GzmB, during effector-to-memory (E/M) differentiation. Foxp3DTRmice were treated with PBS
(+Treg cells) or DT (Treg cells) on days 7, 10, and 13 post-infection with LCMV. Mean and SEM of GzmB MFI in antigen-specific CTLs are presented longi-
tudinally in blood as line graphs. Histogram plots show GzmB expression in DbGP33-specific CD8+ T cells before (day 7) and after (day 22) Treg cell ablation.
Numbers indicate MFI of GzmB (+Treg cells: black solid; Treg cells: gray dotted).
(B) Proliferation of DbGP33-specific, CD44hi, and CD44lo CTLs upon Treg cell ablation during E/M differentiation. BrdU incorporation was used to assess the
percentage of antigen-specific CTLs proliferating on day 12.5 post-infection in FoxP3DTRmice treated with PBS (+Treg cells) or DT (Treg cells) on days 7 and 10
post-infection.
(legend continued on next page)
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RESULTS
Treg Cells Establish and Maintain Quiescence in
Memory CD8+ T Cells by Suppressing Effector Program
and Proliferation
To determine whether Treg cells exert a specific role in the
quiescence of pathogen-specific memory during cognate anti-
gen-free stages, we first conducted a parallel comparison of the
dynamicsof Tregcells andantigen-specificCD8+Tcell responses
following acute LCMV infection. FoxP3+ cytotoxic-T-lymphocyte-
associated protein-4+ (CTLA-4) Treg cell numbers were high dur-
ing the quiescent naive stage prior to infection and also during
post-antigen clearance stages when effector cytotoxic T lympho-
cytes (CTLs) downregulate the expression of effector molecules
such as granzymeB (GzmB), andCD127hi KLRG-1loMPECs pref-
erentially survive anddifferentiate into quiescentmemory (days 16
and 30 after infection) (Figures S1A–S1C). Based on this direct as-
sociation between Treg cell numbers and quiescent phases of
CD8+ T cells, we queried the significance of Treg cells in memory
CTL quiescence using genetically targeted Foxp3DTR mice. Treg
cell ablation resulted in increased expression ofGzmB,with about
2-fold increase in mean fluorescence intensity (MFI) when Treg
cells were absent during E/M transition (Figure 1A) and a 3-
fold increase when Treg cells were ablated during the memory
maintenancephase (Figure1C).Consistentwith this, both specific
and non-specific target cell killing were higher in the absence of
Treg cells (Figure S1D); Treg cell-less CTLs mounted about 3-
fold higher non-specific cytotoxicity toward targets lacking
cognate peptide antigen and elaborated about 2-fold more killing
of peptide-coated targets than their Treg cell-sufficient counter-
parts. While enhanced effector function of Treg cell-less CTLs
has been reported during antigen-driven expansion (Mempel
et al., 2006), these data demonstrate a role of Treg cells in sup-
pressing effector programs andmaintaining quiescence following
pathogen clearance as well.
Contrary to the rapid proliferation associated with antigen-
driven effector expansion phase, development of quiescent
memory is marked by decreased cell turnover during the E/
M transition phase (Sarkar et al., 2008). Likewise, long-term
memory T cell maintenance is also associated with cognate an-
tigen-independent (Murali-Krishna et al., 1999; Swain et al.,
1999) slow homeostatic turnover in response to cytokines IL-7
and IL-15 (Surh and Sprent, 2008). Thus, we next determined
whether loss of quiescence in the absence of Treg cells was(C) Effect of Treg cell ablation on GzmB expression during quiescent memorymain
days 33, 36, and 39 post-infection. Mean and SEMof GzmBMFI in antigen-specifi
DbGP33-specific CTLs before (day 33) and after (day 40) Treg cell depletion are p
Numbers indicate MFI of GzmB expression.
(D) Role of Treg cells in maintaining proliferative quiescence in memory CTLs. P
memory (30 days post-infection) CTLs generated in WT C57BL/6 mice were ado
then treated with PBS or DT (days 0, 3, and 6 after adoptive transfer). Flow plots d
mean and SEM of percentage proliferating memory T cells. Data are presented f
(E) Volcano plot showing fold change in gene expression values for all the 42,10
respect to p values depicting significance of change. Key genes involved in effec
(F) GSEA of effector and memory gene sets in +Treg cell and Treg cell DbGP33
(G) GSEA using cell division gene signature. Rank-ordered expression of genes
Data are representative of more than two independent experiments with 3–5 mi
generated from three independent experimental replicates. Statistical significance
considered not significant (ns). See also Figures S1 and S2.
1118 Immunity 42, 1116–1129, June 16, 2015 ª2015 Elsevier Inc.associated with increased CTL proliferation. As expected, mini-
mal bromodeoxyuridine (BrdU) incorporation was seen in anti-
gen-specific CTLs in Treg cell-sufficient mice (Figure 1B).
However, ablation of Treg cells led to about 3- to 5-fold increase
in proliferating cells, with antigen-experienced tetramer+ and
CD44hi cells specifically incorporating BrdU (Figure 1B). Simi-
larly, preformedmemory T cells also exhibited increased prolifer-
ation rates upon adoptive transfer into Treg cell-less naive mice.
Instead of the slow homeostatic proliferation characteristic of
quiescent memory T cells, loss of Treg cells resulted in about
35%memory CTLs in one or more rounds of division in the short
period of 11 days (Figure 1D).
Genome-wide microarray profiling also confirmed a global
augmentation in effector and proliferation programs upon Treg
cell ablation (Figure S2A). In unsupervised hierarchical cluster
analysis, Treg cell-less CTLs clustered closer to peak effectors,
whereas those developing in Treg cell-sufficient mice were closer
to canonical memory CTLs (Figure S2A). Key transcripts associ-
ated with effector status (such as granzymes, perforin, KLRG-1,
and Blimp-1) and proliferation (such as Ki-67, CDK) were overex-
pressed, and those associatedwithmemory state (such as IL-7Ra
andCCR7)were downregulated in Treg cell-lessCTLs (Figure 1E).
As an unbiased metric of their effector and memory states, gene
set enrichment analysis (GSEA) revealed a strong enrichment of
effector gene signatures in Treg cell-less antigen-specific CTLs
(Figure 1F), with significant enrichment of all currently curated
gene sets characteristic of terminally differentiated effector cells
(Figure S2B). Conversely, Treg cell-less CTLs were specifically
lacking in gene sets associated with functional long-livedmemory
CTLs (Figure 1F). Consistent with increased proliferation of Treg
cell-less memory T cells, we observed a concerted upregulation
of cell cycle genes (Figures S2C and S2D), enhancement of
most gene ontology (GO) pathways of T cell activation and prolif-
eration (FigureS2E), andenrichmentof cell divisiongenesignature
(Figure 1G). Collectively, these data demonstrate that acquisition
and maintenance of memory quiescence not only is a passive
result of lackofTCRstimuli but also requiresTregcells tosuppress
effector and proliferation programs.
Impairment of Hallmark Memory T Cell Functional
Properties upon Loss of Quiescence in the Absence of
Treg Cells
Excessive T cell proliferation is associated with terminal effector
differentiation (Buchholz et al., 2013; Gerlach et al., 2013; Khantenance phase. Mice were treated with PBS (+Treg cells) or DT (Treg cells) on
c CTLs are presented longitudinally in blood as line graphs. GzmB expression in
resented as histogram plots (+Treg cells: black solid;Treg cells: gray dotted).
urified carboxyfluorescein succinimidyl ester (CFSE)-labeled DbGP33-specific
ptively transferred into congenically mismatched Foxp3DTR mice, which were
epict CFSE dilution in spleen 11 days after adoptive transfer. Bar graphs show
rom one of at least two independent experiments with 3–5 mice per group.
1 probes between CTLs differentiating in +Treg cell and Treg cell mice with
tor function, memory differentiation, and proliferation are highlighted.
-specific CTLs.
that are queried as part of the GSEA analysis are presented as a heatmap.
ce per group. Microarray samples for +Treg cell and Treg cell groups were
is indicated by the following: *p% 0.05, **p% 0.01, ***p% 0.001. p > 0.05 was
et al., 2013; Kalia et al., 2010b; Sarkar et al., 2008) during anti-
gen-driven expansion. Based on enrichment of terminal effector
(Figures 1F andS2B) and cell division (Figure 1G) gene sets and a
concomitant loss of memory gene signature in Treg cell-less
CD8+ T cells, we evaluated the impact of Treg cell ablation on dif-
ferentiation, function, and longevity of memory CTLs. Contrary to
their well-known inhibitory effects on effector T cells (Kim et al.,
2007; Lahl and Sparwasser, 2011), we observed that Treg cells
were vital for promoting the development of memory T cells.
Despite increased proliferation (Figure 1B), absolute numbers
of antigen-specific memory CTLs (three distinct LCMV epitopes)
were lower (Figure 2A) following transient Treg cell ablation dur-
ing E/M transition. This correlated with a loss of progressive in-
crease in CD127hi KLRG-1lo antigen-specific MPEC population
(Figure 2B) typically observed during the E/M transition phase
(Joshi et al., 2007; Sarkar et al., 2008). On the contrary, an atyp-
ical increase in the proportion of SLECs occurred (Figure 2B),
suggesting enhanced terminal differentiation in the absence of
Treg cells (Figure S2B). This altered balance of MPECs and
SLECs observed immediately following ablation of Treg cells
was maintained even when Treg cell numbers had rebounded
to normal (Figure 2C). Treg cell-less memory T cells continued
to express higher GzmB (Figure S3A) and comprised signifi-
cantly lower proportions of MPECs compared to Treg cell-suffi-
cient mice, which continued their upward trajectory of MPEC
enrichment (Figures 2D, S3B, and S3C). Closer analysis revealed
a preferential loss of MPECs than SLECs (Figures 2D and S3D).
Notably, altered memory differentiation following ablation of
Treg cells using diphtheria toxin (DT) (Figure S4) was directly
related to absence of Treg cells: (1) Foxp3DTR mice maintained
stable weight through the duration of DT treatment (Figure S4A),
and (2) memory phenotype was alike and unaltered in straight
C57BL/6 mice treated with DT or PBS (Figure S4B). Moreover,
TCR-transgenic as well as endogenous antigen-specific CD8+
T cells manifested similar alterations in memory differentiation
in response to Treg cell ablation (Figures 2A, 2B, 2D, S3, and
S4). Presence of Treg cells was also required to maintain the
CD127hi KLRG-1lo phenotype of preformed memory CD8+
T cells during homeostatic conditions of memory maintenance
phase (Figure 2E). Furthermore, despite increased proliferative
rates (Figure 1D), the total numbers of memory T cells declined
upon Treg cell ablation and were associated with a preferential
loss of CD127hiKLRG-1lo phenotype cells (Figure 2F) in all
lymphoid and nonlymphoid tissues analyzed (data not shown).
We next evaluated the impact of acute loss of Treg cell-depen-
dent quiescence on three cardinal memory functional properties:
(1) polyfunctionality or efficient production of multiple cytokines
(IFN-g, TNF-a, and IL-2) upon antigen challenge; (2) robust sec-
ondary expansion; and (3) ability to persist long term in the
absence of antigen through homeostatic proliferation (Kalia
et al., 2010a; Williams and Bevan, 2007). As expected, differen-
tiation of memory-fated effectors into functional memory T cells
proceeded on a normal schedule in the presence of Treg cells,
with polyfunctional memory evident at about day 22 after infec-
tion (Kaech et al., 2002) (Figure 3A). However, memory T cells
that developed in the absence of Treg cells were compromised
in their ability to co-produce IFN-g, TNF-a, and IL-2 and also pro-
duced lower quantities of cytokines on a per cell basis in
response to in vitro stimulation with five different peptide epi-topes of LCMV (Figure 3A). The decline in polyfunctional CD8+
T cell numbers paralleled the decline in MPEC numbers (Figures
S3D and S3E). Moreover, defects in Treg cell-less memory poly-
functionality progressively worsened over time, as evidenced by
increasing proportions of single cytokine producers and loss of
triple cytokine producers (Figures 3B and S3E) even after Treg
cells had repopulated (Figure 2C).
Additionally, memory CTLs that developed in the absence of
Treg cells underwent significantly less expansion than Treg
cell-sufficient memory cells and were less efficient at controlling
secondary pathogen challenge (Figure 3C). Impaired protective
efficacy of Treg cell-less memory CTLs was associated with
reducedmitochondrial metabolic capacity (Figure 3D), as shown
previously (vanderWindtet al., 2013), andoccurredeven inaTreg
cell-sufficient environment, suggesting that CTL-intrinsic func-
tional defects are imprinted in the absenceof Treg cells. Likewise,
longevity, the third hallmark property of memory T cells, was also
compromised; transient ablation of Treg cells during the E/M
transition phase led to impaired differentiation into CD127hi
CD62Lhi central memory T cells. Consistent with their CD62Llo
phenotype, Treg cell-less memory CTLs were compromised in
their ability to undergo homeostatic proliferation and maintain
stable numbers long term (Figure 3E) when transferred into a
Treg cell-sufficient naive environment without cognate antigen.
Acute loss of Treg cells during the memory maintenance
phase also led to loss of polyfunctionality (Figure 3F), as indi-
cated by an increase in single IFN-g-producing population
from 15% in Treg cell-sufficient memory CTLs to 36% in Treg
cell-less memory CTLs. TNF-a MFI was also significantly
reduced in the absence of Treg cells (Figure 3F). Ablation of
Treg cells at much later time (day > 60 after infection) when
quiescence is more fully effected also caused loss of memory
polyfunctionality (data not shown) and reduced the capacity of
memory T cells to proliferate in response to secondary antigenic
stimulation (Figure 3G) or common g-chain cytokines (Figure 3H).
Taken together, these results clearly show that Treg cells are vital
for imprinting functional properties and longevity in memory
CTLs during E/M transition and also help maintain function
after optimal memory is established.
Compromised Memory Development in the Absence of
Treg Cells Is Independent of Antigen and Prior
Activation of Treg Cells
To determine whether the immunoprotective effects of Treg
cells on LCMV-specificCTLmemory requiredprior activation (Sa-
kaguchi et al., 2008),weperformedadoptive transfer experiments
(Figure 4A) where purified antigen-specific effector CTLs were
adoptively transferred into naive or LCMV-infection-matched
recipients. Naive recipients allowed memory differentiation to
proceed in the presence of polyclonal, unactivated Treg cells,
whereas infection-matched recipients contained LCMV-acti-
vated Treg cells with a higher expression of CTLA-4 and CD25,
albeit in lower numbers (Figures 4B, S1A, and S1B). We also ab-
latedTregcells in a setof naiveor LCMV-infection-matched recip-
ients to determine the impact of naive or LCMV-experienced Treg
cell-less environment. Memory differentiation progressed simi-
larly in Treg cell-sufficient naive and infection-matched recipients,
and both sets of mice contained similar proportions of MPECs
(Figure 4C) capable of robust TNF-a (Figure 4D) and IL-2Immunity 42, 1116–1129, June 16, 2015 ª2015 Elsevier Inc. 1119
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Figure 2. Altered MPEC-SLEC Balance and Decreased Numbers of Antigen-Specific Memory CTLs upon Transient Treg Cell Ablation
(A) Frequency and absolute numbers of LCMV DbGP33-, DbNP396-, and DbGP276-specific CTLs in spleens on days 8 (peak) and 22 (memory) after infection and
DT treatment during E/M transition. Bar graphs show mean and SEM of antigen-specific memory CTL numbers.
(B) CD127 and KLRG-1 expression on DbGP33, DbNP396, and DbGP276 tetramer+ CTLs following Treg cell ablation during E/M transition. Representative flow
cytometry plots (at day 22) along with bar graphs depicting the frequencies (mean + SEM) of CD127hi KLRG-1lo MPECs in blood at indicated times after LCMV
infection are shown.
(C) Transient ablation and subsequent reconstitution of Treg cells. Representative flow cytometery plots showing frequency of FoxP3+CD4+ T cells at day 15 and
day 29 after LCMV infection following depletion of Treg cells during E/M transition are presented. Bar graph shows absolute number (mean + SEM) of
CD4+FoxP3+ Treg cells in spleen at day 38 post-infection.
(D) CD127 and KLRG-1 expression profile of DbGP33-specific CTLs at day 38 post-infection in spleen, following Treg cell ablation during E/M transition. Bar
graphs show absolute numbers (mean + SEM) of DbGP33-specific MPECs and SLECs in spleen.
(E) Impact of Treg cell ablation on phenotypic properties of established DbGP33-specific memory CTLs. 30 days after LCMV infection, Foxp3DTR mice were
administered PBS (+Treg cells) or DT (Treg cells). Frequency of DbGP33-specific CD127hiKLRG-1loMPECs or CD127loKLRG-1hi SLECswere assessed in blood
at indicated times by flow cytometry.
(F) Impact of Treg cell ablation onmemorymaintenance. DbGP33-specificmemory (30 days post-infection) CTLs generated inWTC57BL/6mice were adoptively
transferred into congenically mismatched Foxp3DTRmice, which were then treated with PBS or DT (days 0, 3, and 6 after adoptive transfer) and sacrificed 11 days
post-transfer. Flow cytometry plots depict frequencies of antigen-specific donor cells. Bar graphs showmean and SEM of absolute numbers of donor cells in the
spleen.
Data are representative of 2–5 experiments with 3–5 mice per group. Statistical significance is indicated by the following: *p% 0.05, **p% 0.01, ***p% 0.001.
p > 0.05 was considered ns. See also Figures S2, S3, and S4.
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(Figure 4E) production. These results suggest that prior activation
and antigen specificity are not critical for Treg cell function during
memory differentiation. This notion is further supported by rescue
of memory defects in Treg cell-ablated mice by adoptively trans-
ferred natural Treg cells purified from naive mice (Figure S5D).
Beneficial effects of Treg cell augmentation (Figures 4F and 4G)
on the numbers of total and polyfunctional antigen-specific
CD127hi KLRG-1lo memory CTLs (Figure 4H) further validated
the role of Treg cells in promoting memory. Notably, similar
impairment of memory development in Treg cell-less naive or
infection-matched mice was observed, as marked by evidently
increased SLEC proportions (Figure 4C) and compromised poly-
functionality (Figures 4D and 4E). Collectively, these data demon-
strate that Tregcellspromotememorydifferentiation independent
of cognate antigen or other LCMV-specific signals and that prior
activation of Treg cells is not critical.
Differential Effects of Treg Cells on MPEC and SLEC
Subsets during E/M Transition
Preferential loss of MPECs (Figure 2D) upon Treg cell ablation
during memory conversion suggested a specific role of Treg
cells in promoting the shift of MPECs from a charged effector
state toquiescentmemory state. Togain insight into Tregcell-de-
pendent cellular processes involved in E/Mshift, we compared
survival, proliferation, and inter-conversion of MPEC and SLEC
subsets using direct ex vivo and in vivo analyses of (1) cell
numbers, (2) death markers, (3) terminal differentiation, and (4)
proliferation.
Adoptive transfer of purified KLRG-1lo and KLRG-1hi subsets
into Treg cell recipients led to an evident upregulation of
GzmB expression (Figures 5A and 5B). Additionally, purified
KLRG-1lo MPECs transitioned into the more terminally differenti-
ated KLRG-1hi phenotype inTreg cell mice (Figures 5A and 5B).
On the other hand, consistent with their terminally differentiated
status (Figure S2), KLRG-1hi SLECs remained KLRG-1hi and un-
derwent greater death than MPECs in both +Treg cell andTreg
cell mice. However, the difference in SLEC recoveries from+Treg
cell and Treg cell mice was modest. In contrast, KLRG-1lo
MPECs were recovered in significantly fewer numbers upon
adoptive transfer into Treg cell-ablated mice compared to
wild-type (WT) mice (Figure 5C). This was associated with
modestly greater upregulation of death receptors Fas and
TNFRII and increased caspase-3 cleavage inMPECs (Figure 5C),
albeit both effector subsets upregulated these markers in Treg
cell mice, consistent with greater Annexin V staining than +Treg
cell mice. With respect to polyfunctionality, MPECs and SLECs
exhibited significant increase in single IFN-g-producing cells
and a decrease in the expression of TNF-a (Figure 5D) in the
absence of Treg cells, suggesting that loss of polyfunctionality
at a population level (Figures 3A, 3B, and S3) was likely due to
specific loss of MPECs (which comprise the majority of the triple
cytokine producers) and loss of cytokine production by SLECs
as well. Loss of memory potential in MPECs was associated
with preferentially increased proliferation of MPECs during E/
M transition (days 12.5, 15, and 16) as well as during memory
maintenance phase (day 40 post-infection) in Treg cell-ablated
mice (Figures 5E and 5F). Thus, even though both subsets ex-
hibited increased proliferation, loss of function, and death
upon Treg cell ablation, loss of Treg cells exerted a more pro-found impact on MPECs than SLECs. Collectively, these data
demonstrate that Treg cells are required to suppress terminal
effector differentiation and excessive proliferation and promote
the survival of MPECs and enhance their differentiation into pol-
yfunctional memory T cells.
Treg Cells Promote Memory Development and Function
through the CTLA-4-CD28 Axis
To gain insight into the mechanism by which Treg cells
mediate quiescence in memory-fated T cells, we next scanned
the transcriptome of Treg cell-less CTLs for evidence of
dysregulated signaling. We observed a specific enrichment
of genes belonging to the IL-2 reactome in memory CTLs
developing in the absence of Treg cells (Figure S5A). However,
blocking or enhancing excessive IL-2 signals exerted minimal
impact on MPEC frequency (Figure S5B), GzmB expression
(Figure S5B), or impaired polyfunctionality (Figure S5C)
observed in the absence of Treg cells. Likewise, CD25-
blocked and unmanipulated nTreg cells mediated similar
phenotypic and functional rescue of memory CTLs (Fig-
ure S5D). Reduced IL-2 production by Treg cell-less CD8+
(Figures 3A, 3B, and 3F) and CD4+ T cells (Figure S5E) and
largely similar serum concentrations of IL-2 in WT and Treg
cell-depleted mice (Figure S5F) further suggested that IL-2
deprivation is not the primary means by which Treg cells pro-
mote memory quiescence.
We next shifted our attention to CD28, a co-stimulatory recep-
tor (Acuto and Michel, 2003) that provides the ‘‘second signal’’
and synergizes with TCR signals to promote IL-2 production,
expansion, and effector differentiation. Enrichment of the CD28
reactome in Treg cell-less memory CTLs (Figure S6A) prompted
further interest because Treg cells express high amounts of cell
surface CTLA-4 (Figure S1B)—an inhibitory receptor that com-
petes with CD28 for common ligands, B7-1 (CD80) and B7-2
(CD86), typically expressed on antigen-presenting cells (APCs)
(Figure S6B) (Josefowicz et al., 2012). Analysis of CD28 expres-
sion revealed higher cell surface protein as well as mRNA in
memory T cells than in naive cells (Figures 6A and 6B), withmem-
ory-fated cells expressing modestly higher CD28 throughout dif-
ferentiation (Figure 6A). CD28 stimulation through CD80, CD86,
or both resulted in about 40- to 150-fold recovery of memory
T cells (Figure 6C), whereas naive cells responded minimally.
These data are consistent with minimal proliferation of naive
CD44lo CTLs upon Treg cell ablation, compared to CD44hi
antigen-experienced memory-fated CTLs (Figure 1B). How-
ever, supraphysiological transduction of CD28 signals using
superagonist antibody (Tacke et al., 1997) resulted in similar re-
coveries of naive and memory CTLs (Figure 6C). Together, these
data demonstrate that albeit both naive and memory CD8+
T cells are capable of CD28 signal transduction even in the
absence of cognate antigen, memory T cells respond more
readily to CD28 ligation through B7.
Considering the high expression of CTLA-4 on Treg cells and
its 10-fold-higher affinity for B7 than CD28, our data, demon-
strating (1) enhanced responsiveness of memory CTLs to
CD28 ligation and (2) modest decrease in CD28 expression
upon Treg cell ablation (both transcript amounts [Figure S6A]
and protein expression [Figure S6C]) in LCMV-specific CTLs,
present a model for Treg cell-mediated memory quiescenceImmunity 42, 1116–1129, June 16, 2015 ª2015 Elsevier Inc. 1121
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Figure 3. Compromised Functional Properties of Pathogen-Specific Memory CTLs upon Transient Loss of Treg Cells
(A–D) Foxp3DTRmicewere infected with LCMV and treated with PBS (+Treg cells) or DT (Treg cells) during E/M transition, and functional properties of memory
CTLs were analyzed.
(A) Cytokine production by antigen-specific cells from day 22 spleens of +Treg cell and Treg cell mice after 5 hr in vitro peptide re-stimulation. Representative
flow cytometry plots show intracellular staining of IFN-g, TNF-a, and IL-2 with or without GP33 peptide re-stimulation. Summary bar graphs of frequency of CTLs
co-producing indicated cytokines and MFI are also presented.
(B) Polyfunctionality of memory CTLs. Line graphs show cytokine production by antigen-specific CTLs at indicated times post-infection, as assessed by the
proportion of antigen-specific (IFN-g+) CTLs producing single (IFN-g only), double (IFN-g and TNF-a), or triple (IFN-g, TNF-a, and IL-2) cytokines.
(legend continued on next page)
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through CTLA-4 by blocking B7 triggering of CD28 on memory
T cells (Figures S6D and S6E). Consistent with this proposal,
in vivo administration of soluble CTLA-4 Ig reinstated quies-
cence (reduced Gzm B expression) and rescued the defects
in memory polyfunctionality associated with loss of Treg cells
(Figure 6D). Likewise, exogenous CTLA-4 Ig successfully re-
placed Treg cells during E/M transition as well (Figure 7A).
Blockade of excessive CD28 signaling in the absence of Treg
cells (Figure 7A) also rescued defective memory differentiation,
as indicated by (1) rescue of MPEC frequencies (Figure 7B) in-
dependent of precursor frequency (Figure S7A), (2) maintained
suppression of effector program despite Treg cell ablation, as
depicted by lower GzmB expression (Figures 7B and S7A),
and (3) partial to full functional rescue of Treg cell-less memory
T cells with respect to IFN-g and TNF-a coproduction, as well as
total production of TNF-a (Figures 7C and S7B). IL-2 production
also increased modestly upon CTLA4-Ig treatment (Figures 7C
and S7B). Notably, secondary expansion potential of Treg
cell-less memory T cells was also partially rescued by CTLA4-
Ig (Figure S7C).
CTLA4-Ig treatment of Treg cell-ablated mice completely
restored the chemokine and cytokine homeostasis of Treg cell-
ablated mice to WT concentrations (Figure 7D). Parallel alter-
ations in inflammatory chemokines (e.g., CCR5) and cytokines
(e.g., interferon-g, IL-12, IL-1) (Figure 7D) and their receptors in
Treg cell-less memory CD8+ T cells (Figure S7D) and increased
expression of IL-12-induced T-box transcription factor T-bet
(key driver of terminal differentiation) (Figure S7E) implicate a
role of inflammatory mediators in further amplifying the expan-
sion and terminal differentiation of Treg cell-less memory
T cells and regulating their localization (Figure S7F). However,
our data, demonstrating (1) enhanced CD28 expression and
signaling in memory CTLs, (2) alterations in CD28 reactome in
Treg cell-less memory CTLs, (3) rapid increase in GzmB expres-
sion and CTL cell proliferation immediately after Treg cell deple-
tion (Figure 1), when the inflammatory signals remain largely(C) Secondary expansion and protective efficacy ofmemory CTLs developing in th
(Thy1.1+) were isolated at day 22 after LCMV infection from the spleens of +Tre
adoptively transferred into naive C57BL/6 mice followed by challenge with rLM-G
CTLs at 5.5 days post-challenge are presented, along with rLM-GP33 titers in sp
(D) Mitochondrial metabolic potential of antigen-specific CTLs in the absence of
CTLs from spleens of +Treg cell and Treg cell mice were analyzed for their abil
incubation at 37C. Gray histograms represent background MFI of Resorufin in m
(E) Homeostatic proliferation of antigen-specific memory CTLs differentiated in th
memory T cells (Thy1.1+) were isolated from +Treg cell and Treg cell P14 chi
adoptively transferred into naive C57BL/6 mice. Representative flow plots show
CTLs in spleen at day 70 after transfer. CD8+Thy1.1+ donor cells were selected fr
CD62L expression. The gray histogram represents CD62L expression in naive C
(F) Regulation of polyfunctionality of memory CTLs by Treg cells during memory m
in Foxp3DTRmice were assessed at day 40 after LCMV infection for their ability to
peptide in vitro. The frequency of memory CTLs producing one, two, or all three cy
Average MFI and SEM of TNF-a on a per cell basis is presented as a bar graph.
(G) Protective efficacy of late memory T cells upon Treg cell ablation. Equal n
transferred into naive C57BL/6 mice followed by challenge with rLM-GP33. Bar g
4.5 post-challenge.
(H) Expansion potential of late (>day 200) memory CTLs in response to commo
spleens of WT or Treg cell-ablated mice. Fold recovery over unstimulated antigen
in vitro stimulation with IL-2, IL-7, or IL-15 and are presented as bar graphs dep
Data are representative of >3 experiments with 3–6 mice per group. Statistical sig
0.05 was considered ns. See also Figure S3.unchanged (data not shown), and (4) ability of soluble CTLA-4
Ig to completely reinstate chemokine and cytokine homeostasis
and rescue memory defects associated with loss of Treg cells
(Figure 7D), delineate CTLA-4 as the primary initiating signal for
Treg cell-mediated memory CTL quiescence.
DISCUSSION
Considerable progress has been made in understanding the
mechanisms regulating commitment to effector and memory
lineages. However, much less is known about the processes
regulating the differentiation and long-term maintenance of
memory T cells in a quiescent state. Our studies demonstrate
that Treg cells serve to suppress proliferation and effector pro-
grams during memory differentiation and prevent terminal dif-
ferentiation of CD127hi KLRG-1lo MPECs. CD44hi CTLs that
proliferate upon Treg cell ablation largely comprise LCMV-spe-
cific cells, as 85%–95% of CD44hi cells are accounted for by at
least ten different LCMV epitopes from two of the four LCMV
proteins in infected mice (Masopust et al., 2007). However, it
is conceivable that a small fraction of CD44hi cells may consist
of non-LCMV-specific naive CTLs responding to environmental
(or self) antigens or deregulated cytokines. Notwithstanding,
increased proliferation of memory T cells even in adoptive
transfer settings, where MPECs or fully differentiated memory
T cells were transferred into antigen-free naive mice strongly
supports the notion that memory quiescence not only is a pas-
sive result of lack of TCR stimuli but also requires immunosup-
pression by Treg cells.
A variety of immunosuppressive mechanisms have been pro-
posed by which Treg cells regulate autoimmunity (Wing and
Sakaguchi, 2010): production of immunosuppressive cytokines,
such as TGF-b and IL-10; effector cell deprivation of IL-2; func-
tional modification of APC to downregulate B7 through CTLA-4;
alteration of dendritic cell (DC) metabolism; and direct contact-
dependent delivery of negative signals or elevation of cyclice absence of Treg cells during E/M transition. DbGP33-specificmemory CTLs
g cell and Treg cell P14 chimeric Foxp3DTR mice. Equal numbers (104) were
P33. Representative frequencies and total numbers of donor DbGP33-specific
leen at day 4.5 post-challenge.
Treg cells during E/M transition. At day 15 post-infection, DbGP33-specific
ity to reduce non-fluorescent Resazurin into fluorescent Resorufin after 15 min
etabolically inactive cells.
e presence or absence of Treg cells during E/M transition. DbGP33-specific
meric Foxp3DTR mice as in (C), labeled with CFSE, and equal numbers were
donor CTLs on days 1 or 70 post-transfer. Bar graph shows number of donor
om live lymphocyte gate and analyzed for CFSE dilution, CD127, KLRG-1, and
D8 T cells.
aintenance. Memory CTLs maintained in the presence or absence of Treg cells
co-produce intracellular IFN-g, TNF-a, and IL-2 upon re-stimulation with GP33
tokines is depicted as pie charts. Numbers in pie charts represent mean values.
umbers of DbGP33-specific late memory (>day 200) CTLs were adoptively
raphs show donor DbGP33-specific CTLs and rLM-GP33 titers in spleen at day
n g-chain cytokines IL-2, IL-7, and IL-15. Memory T cells were isolated from
-specific CTLs from +Treg cell or Treg cell mice were determined after 60 hr
icting mean and SEM values.
nificance is indicated by the following: *p% 0.05, **p% 0.01, ***p% 0.001. p >
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Figure 4. Antigen Specificity of the Treg Cells Is Not Critical for Mediating Functional Differentiation of CTL Memory
(A) Experimental setup. LCMV-infected C57BL/6mice (Thy 1.2+) adoptively transferred with 104 P14 TCR-transgenic DbGP33-specific CTLs (Thy 1.1+) were used
to purify Thy1.1+ CD8+ effector T cells at day 7 after infection (>99%purity). About 303 106 purified cells were adoptively transferred into either Foxp3DTR naive or
day 7 LCMV-infection-matched mice. Recipient mice were treated with either PBS (+Treg cells) or DT (Treg cells) on days 1, 4, and 7 post-transfer. Mice were
sacrificed on day 15 post-transfer, and donor CTLs were analyzed for memory properties.
(B) Phenotypic properties of Treg cells in naive and LCMV-infected mice. Representative flow cytometry plots depicting frequencies of Treg cells in peripheral
blood mononuclear cell (PBMC) samples from naive (day 0) and LCMV-infected (day 7) mice and histograms showing expression of CTLA-4 and CD25 on CD4+
FoxP3- non-Treg cells (gray) and CD4+ FoxP3+ Treg cells (black) are shown.
(C) Analysis of CD127 and KLRG-1 expression on donor CTLs. Representative flow cytometry plots are shown along with a bar graph of % antigen-specific cells
that possess CD127hiKLRG-1lo MPEC phenotype.
(D and E) Polyfunctionality of memory T cells. Donor CTLs from the spleens of recipient mice were analyzed for intracellular cytokine (IFN-g, TNF-a, IL-2) pro-
duction following 5 hr re-stimulation with no peptide (gray histogram) or GP33 peptide from LCMV glycoprotein (black: +Treg cells; gray dotted: Treg cells).
(F and G) Effect of Treg cell augmentation on E/M transition.
(F) Experimental setup. C57BL/6 mice were infected with LCMV and sacrificed on day 8 post-infection. DbGP33-specific CTLs were transferred into naive WT or
Treg cell-expanded (Treg cells [[) mice, which were sacrificed 14 days later.
(G) Flow cytometry plots depict frequency of FoxP3+ cells of CD4+ T cells in recipient mice after Treg cell expansion prior to cell transfer.
(H) Representative flow cytometry plots showing frequencies of donor CTLs in spleens at day 14 post-transfer are presented along with bar graphs showing
numbers (mean and SEM) of antigen-specific (IFN-g+) MPEC or polyfunctional CTLs in the spleen.
Data are representative of two experiments with 3–5 mice per group. Statistical significance is indicated by the following: *p% 0.05, **p% 0.01, ***p% 0.001.
p > 0.05 was considered ns. See also Figure S5.
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Figure 5. Differential Effects of Treg Cell Ablation on Differentiation, Survival, and Proliferation of MPECs and SLECs
(A) Experimental setup. WT DbGP33-specific effector CTLs were purified by FACS into KLRG-1lo MPECs or KLRG-1hi SLECs and adoptively transferred into
congenically mismatched WT (+Treg cells) or Foxp3DTR (Treg cells) mice treated with DT on days 3, 0, and 3 post-transfer. MPEC and SLEC subsets were
analyzed in blood over time and in spleen at day 13 after transfer.
(B) Analysis of MPEC and SLEC differentiation in +Treg cell and Treg cell mice as assessed by CD127 and KLRG-1 expression in PBMC at indicated times.
Representative flow cytometry plots are shown. MFI of GzmB in purified MPEC and SLEC subsets in spleen are plotted as a bar graph.
(C) Survival potential of MPECs and SLECs upon Treg cell ablation. Apoptosis was assessed in total DbGP33-specific CTLs by flow cytometry analysis of Annexin V
and7-AADstaining inspleens followingTregcell ablationduringE/Mtransition.Bar graphsshowtotal numbersofpurifiedMPECandSLECdonorcells isolated from
spleens of +Treg cell andTregcell recipientmice, alongwithMFI of cell surface expression of death receptors Fas andTNFRII and intracellular cleaved caspase-3 in
MPECs and SLECs. Error bars depict SEM.
(D) Polyfunctionality of purified MPECs and SLECs differentiating in +Treg cell and Treg cell mice. Pie charts depict proportions of MPECs and SLECs
capable of single (IFN-g), double (IFN-g and TNF-a), or triple (IFN-g and TNF-a and IL-2) cytokine production after 5 hr in vitro re-stimulation with GP33
peptide. TNF-a expression in MPEC and SLEC subsets are presented as histogram plots (light gray: unstimulated; dark gray: Treg cells; black line: +Treg
cells), and bar graphs depict median fluorescence intensity + SEM.
(E) Relative proliferation of CD127hiKLRG-1lo phenotype DbGP33-specific MPECs and CD127loKLRG-1hi phenotype SLECs upon Treg cell ablation during E/M
transition. Treg cell ablation was initiated by DT administration at day 7 post-infection and BrdU incorporation in DbGP33-specific CTLs was assessed by flow
cytometry on days 12.5, 15, and 16 post-infection. Bar graphs show ratio of % BrdU+ MPECs and SLECs.
(F) Relative proliferation of CD127hiKLRG-1lo andCD127loKLRG-1hi phenotypeDbGP33-specific cells upon Treg cell ablation duringmemorymaintenance phase.
Purified CFSE-labeled memory (30 days post-infection) CTLs were adoptively transferred into congenically mismatched Foxp3DTRmice, which were then treated
with PBS or DT (days 0, 3, and 6 after adoptive transfer). Flow plots depict CFSE dilution in spleen 11 days after adoptive transfer of memory T cells. Bar graphs
show percentage of non-proliferating MPECs and SLECs in spleen as means and SEM.
Data are representative of at least two experiments with three mice per group. Statistical significance is indicated by the following: *p % 0.05, **p % 0.01,
***p% 0.001. p > 0.05 was considered ns. See also Figures S2 and S3.
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Figure 6. Maintenance of Memory T Cell Quiescence and Function through CTLA-4
(A) Cell surface expression of CD28 on antigen-specific naive, early (day 4.5) or late (day 8.0) MPECs and SLECs and memory T cells (day 60) were assessed by
flow cytometry. DbGP33-specific (Thy1.1+) MPECs and SLECs were distinguished on the basis of CD127 and KLRG-1 expression.
(B) CD28 mRNA expression in naive and memory (>day 60 after LCMV infection) DbGP33-specific CTLs are presented from previously published (Sarkar et al.,
2008) microarray dataset from GEO database (accession number GSE10239).
(C) CD28 signal transduction in naive and memory T cells. Purified (>95%) naive and day > 60 memory P14 cells were stimulated with plate-bound CD80, CD86
(singly or in combination), and superagonist anti-CD28 antibody. Cell numbers were enumerated, and fold recovery of stimulated over unstimulated samples are
presented as bar graphs.
(D) Foxp3DTRmice were infected with LCMV, and at days 30, 33, and 36 after infection, mice were treated with PBS (+Treg cells) or with DT (Treg cells). One set
of Treg cell-depleted mice was concurrently treated with CTLA4-Ig. Mice were sacrificed on day 40 after infection, and GzmB expression and cytokine poly-
functionality following 5 hr re-stimulation with GP33 peptide in vitro were assessed. Flow cytometry plots from representative mice are presented. Bar graphs
show MFI + SEM of indicated molecules. Pie charts show single, double, and triple cytokine-producing GP33-specific memory CTLs.
Data are representative of at least two experiments with 3–5 mice per group. Statistical significance is indicated by the following: *p % 0.05, **p % 0.01,
***p% 0.001. p > 0.05 was considered ns. See also Figure S6.
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Figure 7. Dominant Role of CTLA-4 in Restoring the Development of
Quiescent, Functional Memory CTLs in the Absence of Treg Cells
(A) Experimental setup. LCMV-infected Foxp3DTR mice were treated with
either PBS (+Treg cells) or DT (Treg cells) during E/M transition. A set of DT-
treated mice was also concurrently administered CTLA-4-Ig or anti-CD28.
Mice were sacrificed on day 20 after infection for analysis of phenotype and
function.
(B) Phenotypic properties of antigen-specific CTLs. Flow cytometry plots de-
pict expression of CD127, KLRG-1, and GzmB on splenic DbGP33-specific
CTLs. Bar graphs show%MPECs and GzmBMFI for DbGP33, DbNP396, and
DbGP276 epitopes of LCMV.Numbers inGzmBhistogramplots representMFI.
(C) Polyfunctionality of antigen-specific CTLs. Polyfunctionality was deter-
mined by measuring intracellular cytokine production in spleens following 5 hr
in vitro re-stimulation with indicated peptide epitopes from LCMV glycoprotein
and nucleoprotein.
(D) Serum concentrations of indicated cytokines and chemokines in +Treg
cells and Treg cells and Treg cells + CTLA-4-Ig mice at day 22 post-
infection. Average concentrations are presented in pg/mL ± SEM.AMP (Sakaguchi et al., 2008). Our data suggest that IL-2
deprivation is likely not a predominant mechanism by which
Tregs promote E/M transition and present a three-molecule
(CTLA-4, CD28, and B7) model of Treg cell-mediated memory
quiescence. Since effector and proliferation gene loci are
epigenetically open and more readily transcribed in memory
CTLs (Weng et al., 2012), it is possible that minimal signaling
through CD28 in the absence of Treg cells is sufficient to drive
memory T cell activation. This is supported by evident T cell
proliferation in the absence of TCR engagement following
CD28 crosslinking with superagonist antibody or B7 (Tacke
et al., 1997).
In a phase I human clinical trial, CD28-SuperMAB administra-
tion was found to induce amassive cytokine storm (Hu¨nig, 2012).
Our data, demonstrating induction of inflammatory cytokines in
the absence of Treg cells and their suppression to homeostatic
concentrations by soluble CTLA-4, suggest that aberrant T cell
(both CD4+ and CD8+) stimulation through CD28 in the absence
of Treg cells may further exacerbate memory dysfunction
through deregulated production of secondary inflammatory me-
diators. The broader expression pattern of B7 and the release of
secondary inflammatory mediators upon Treg cell ablation
also explain the non-antigen-dependent aspect of the phenom-
enon. An altered pattern of chemokine expression has been
associated with expansion of low-avidity CTLs (Pace et al.,
2012), reduced trafficking of effector T cells to peripheral sites
of infection, and increased pathogen burden (Lund et al., 2008)
upon Treg cell ablation during T cell priming. In antigen-indepen-
dent phases of memory, our studies did not identify any promi-
nent defects in T cell localization at the peripheral organs, albeit
a modest increase in lymph node localization was observed
following Treg cell ablation. This correlated with increased
expression of inflammatory chemokines such as CCL5 and
CCL2 and parallel changes in expression of respective chemo-
kine receptors on Treg cell-less memory T cells. Additionally, a
more profound effect of Treg cell ablation on MPECs and previ-
ous reports that CD127hi KLRG-1lo memory-fated CTLs prefer-
entially localize in the lymph nodes (Kalia et al., 2010b; Sarkar
et al., 2008; Yuzefpolskiy et al., 2014) present lymph nodes as
a potential regulatory site for Treg cell-dependent memory
quiescence.
Our observations that Treg cells have the highest expression
of CTLA-4 and that soluble CTLA-4 alone fully reverses memory
defects observed in the absence of Treg cells establish CTLA-4
as a critical upstream mediator of Treg cell-dependent memory
quiescence. The importance of CTLA-4 in normal immune ho-
meostasis is validated in humans by evident dysregulation of
Treg cells, hyperactivation of effector T cells, and loss of B cells
in CTLA-4 haploinsufficiency (Kuehn et al., 2014). Additionally,
while absence of CTLA-4 on Treg cells may be associated with
compensatory suppressive mechanisms in vitro, CTLA-4 is
critical for Treg cell function in vivo (Sojka et al., 2009). Future
studies involving cell-type-specific deletion of CD80, CD86,
CTLA-4, and CD28 will reveal whether Treg cells serve toData are representative of two experimentswith 3–5mice per group. Statistical
significance is indicated by the following: *p% 0.05, **p% 0.01, ***p% 0.001.
p > 0.05 was considered ns. See also Figure S7.
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physically block weak, non-antigen-specific interactions be-
tween memory T cells and DCs by directly binding CD80 and/
or CD86 through CTLA-4 or by decreasing expression of
CD80, CD86 (Josefowicz et al., 2012; Sakaguchi et al., 2008),
or other adhesion molecules on DCs. In addition, gene deletion
and complementation studies of deregulated inflammatory che-
mokines and cytokines combined with intravital imaging of
CTLs, Treg cells, and APCswill clarify the precise secondaryme-
diators and the role of microniches in driving Treg cell-depen-
dent memory quiescence.
In addition to providing mechanistic insight into the Treg cell-
memory T cell nexus, this study provides a potential strategy for
accelerating and enhancing CTL memory during vaccination.
These studies also highlight the importance of timely regulation
of CD28 signals to enhance immunological memory following
antigen clearance in immunotherapeutic settings of Treg cell
ablation presently under consideration for treatment of cancer.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 mice were purchased from the Jackson Laboratory. Thy1.1+ H-2Db
GP33-specific TCR-transgenic P14 mice were fully backcrossed to C57BL/6
mice and maintained in our colony. Foxp3DTR mice were kindly provided by
Dr. Alexander Rudensky (Memorial Sloan-Kettering Cancer Center). All
animals were used in accordance with Institutional Animal Care and Use
Committee guidelines. Armstrong strain of LCMV and recombinant Listeria
monocytogenes (rLM-GP33) were propagated, titered, and used as previously
described (Sarkar et al., 2008).
Administration of DT
DT was purchased from Sigma Aldrich, and each lot was titered for potency in
Foxp3DTRmice prior to use. The optimal dosage to effectively ablate Treg cells
was 20–25 ng/g administered three times, with 2-day interval between
injections.
Generation and Isolation of Effector, MPEC, SLEC, and Memory T
Cell Subsets
Effector or memory CD8+ T cells were isolated from spleens of LCMV-infected
C57BL/6mice containing 105 antigen-specific P14CD8+ T cells (Thy1.1 homo-
zygous) at day 7 or day > 30 after infection bymagnetic bead purification (Stem
Cell Technologies). For analysis of purified MPEC and SLEC subsets, CD8+
T cells were isolated from day 10 splenocytes using negative CD8+ T cell
bead purification (Stem Cell Technologies), followed by fluorescence-acti-
vated cell sorting (FACS) sorting into CD8+ KRLG-1lo MPECs and CD8+
KLRG-1hi SLECs using MoFlo Astrios (Beckman Coulter). Purities were
confirmed at 95%–99%, and equal numbers (1.5 3 106) were adoptively
transferred into WT or Foxp3DTR mice treated with DT at days 2, 1, and 4
post-transfer.
Flow Cytometry
All antibodies were purchased from Biolegend with the exception of GzmB (In-
vitrogen). Cells were stained for surface or intracellular proteins and as previ-
ously described (Sarkar et al., 2008). Cell proliferation analyses are presented
in Supplemental Experimental Procedures. LSRII Fortessa (BD Biosciences)
was used for data acquisition.
Microarray Samples
Developing memory CD8+ T cells (16 days after infection) were purified by flow
cytometry sorting from splenocytes of Thy1.1 homozygous P14 chimeric
Foxp3DTR mice injected intraperitoneally with 500 mL PBS or DT on days 7,
10, and 13 after infection. RNA was isolated using Trizol (Invitrogen) (Kalia
et al., 2010b). Subsequent cDNA, cRNA synthesis, and hybridization to mouse
430.2microarray chips (Affymetrix) were performed according to themanufac-
turer’s protocol at Penn State Genomics Core Facility.1128 Immunity 42, 1116–1129, June 16, 2015 ª2015 Elsevier Inc.Administration of Antibodies and CTLA-4 Ig
CTLA-4 Ig (500 mg), anti-CD28 (PV-1) (200 mg), or PBS were administered
intraperitoneally on days 7, 10, and 13 after infection of Foxp3DTR mice
along with DT. CTLA4-Ig was kindly provided by Dr. Steven G. Nadler
in the Immunosciences Translational Research Division at Bristol-Myers
Squibb.
Treg Cell Augmentation
Uninfected C57BL/6 mice were administered IL-2 (Peprotech)-anti-IL-2
(JES6-1A12) immune complexes or PBS (control) as described previously
(Webster et al., 2009) on days 6, 5, and 4 prior to adoptive transfer of
purified effector CTLs.
Serum Cytokine and Chemokine Analysis
Serum samples were collected at day 22 from LCMV-infected Foxp3DTR mice
that were treatedwith PBS or DT. Serum concentrations of indicated cytokines
and chemokines were assessed by Luminex multiplex assay (Millipore) per the
manufacturer’s instructions.
In Vitro Stimulation of CD28
96-well flat bottom plates were coated with CD80-Ig, with CD86-Ig (R&D Sys-
tems) singly or in combination, or with superagonist anti-CD28 antibody
(CD28SA, clone D665; a kind gift from Dr. Thomas Hu¨nig from University of
Wu¨rzburg at Germany) to stimulate equal numbers of purified naive and mem-
ory P14 CD8+ T cells as described previously (Tacke et al., 1997). Live cells
were enumerated, and fold recovery of stimulated over unstimulated samples
was determined.
Statistical Analysis
Unpaired Student’s t test was used to evaluate differences between sample
means of two groups. One-way ANOVA was performed when comparing
multiple groups, followed by a Tukey test to determine significance of
differences between two means. Mixed ANOVA was performed when
analyzing longitudinal data. Mixed ANOVA was performed using IBM
SPSS 22. All other statistical analyses were performed using Prism 5 and
p values of statistical significance are depicted by asterisk per the Michelin
guide scale.
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